Results 2,361-2,380 of 3,336 for speaker:Kate O'Connell
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: Are there figures for the number of GPs who advertise and provide specific women's health services and have, in-house, their own ultrasound machines? There seems to have been an emergence of them in recent years for early dating of pregnancy.
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: If a GP had one of these €15,000 ultrasound machines, are GPs already able to use them or does a course have to be done to use them, a refresher, or a continuing professional development, CPD, evening, or such?
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: Is it fair to say that GPs will not be looking for these ultrasound machines that cost approximately €15,000 to do the procedure in under nine weeks in their surgery?
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: As the witnesses have referenced, there is little evidence to support a three-day wait. Recently, Dr. O'Brien said that there might be some instances of harm. I ask him or his colleagues to elaborate on the matter now or even after the meeting as it is important.
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: That brings us back to our initial discussion with Dr. Favier.
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: We invited the witnesses here to give their professional opinions. Do our general practitioner witnesses and those representing the Irish College of General Practitioners believe it fair to say that the three-day waiting period could be dealt with through guidelines or left to the discretion of doctors depending on the individual circumstances of each case and that to impose legislative...
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: As the Chairman is aware, I have spent a lot of time attending meetings of this committee and the Joint Committee on the Eighth Amendment of the Constitution. I ask that the clerk compile a graph illustrating Senator Mullen's attendance when issues-----
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: -----of a gynaecological nature are under discussion. His attendance at the health committee when such issues are being discussed seems to be far more frequent than for any other issue.
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: I refer to the repeated use of the term "elective services" by a member of the committee in reference to abortion. Elective services are those which are scheduled in advance because they do not involve a medical emergency. To class women seeking an abortion as attempting to access elective services is to try to diminish women. I believe that member has failed in his pathetic attempt to do...
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: The Chairman is a medical doctor and did not pull the member up on that usage of the phrase "elective services".
- Joint Oireachtas Committee on Health: Clinical Guidelines for the Introduction of Abortion Services: Discussion (19 Sep 2018)
Kate O'Connell: It is totally disrespectful to women.
- Joint Oireachtas Committee on Health: Licensing of Abortion Medication: Health Products Regulatory Authority (19 Sep 2018)
Kate O'Connell: In the opening statement, reference was made to the second tablet that contains either Misoprostol or Gemeprost. Is either more effective? Is the Misoprostol the first line and if there is none available, is Gemeprost an equivalent? I am just trying to establish that we get the optimum product. Dr. Breslin referred to more than one company. While I understand the commercial sensitivity,...
- Joint Oireachtas Committee on Health: Licensing of Abortion Medication: Health Products Regulatory Authority (19 Sep 2018)
Kate O'Connell: We heard earlier that one could be looking at 10,000 procedures a year and then if 70% happen before ten weeks, one is looking at potentially 7,000 doses of product. Would that be considered a niche market? I am concerned about the small population size and price and being caught in January having to pay. Is ten or 100 people niche?
- Joint Oireachtas Committee on Health: Licensing of Abortion Medication: Health Products Regulatory Authority (19 Sep 2018)
Kate O'Connell: I thank Mr. Lynch.
- Joint Oireachtas Committee on Transport, Tourism and Sport: MetroLink Project: Discussion (18 Jul 2018)
Kate O'Connell: I thank the representatives of Rethink MetroLink for appearing before the committee. I also thank them for their work on behalf of people in the communities in the constituency of Dublin Bay South who could be affected by this emerging preferred route. I thank my constituency colleagues, Deputies Eamon Ryan and O'Callaghan, for engaging in a collective way. We do not necessarily agree on...
- Public Accounts Committee: 2016 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Chapter 23: Accounts of the National Treasury Management Agency
National Treasury Management Agency: Financial Statements 2017 (12 Jul 2018) Kate O'Connell: I had intended starting with the opening statement, however I first turn to CervicalCheck, following the information highlighted by Mr. Breen. I understand that previously, he was clear in acknowledging that there were potentially other cases. However, from what has been highlighted here this morning, I understand there may be further deficiencies in our testing system and there may be...
- Public Accounts Committee: 2016 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Chapter 23: Accounts of the National Treasury Management Agency
National Treasury Management Agency: Financial Statements 2017 (12 Jul 2018) Kate O'Connell: I am not talking about compensation or the whole package; I am talking about the non-disclosure element and the State's liability.
- Public Accounts Committee: 2016 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Chapter 23: Accounts of the National Treasury Management Agency
National Treasury Management Agency: Financial Statements 2017 (12 Jul 2018) Kate O'Connell: In Mr. Breen's view.
- Public Accounts Committee: 2016 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Chapter 23: Accounts of the National Treasury Management Agency
National Treasury Management Agency: Financial Statements 2017 (12 Jul 2018) Kate O'Connell: Has Mr. Breen asked the patients affected what they would like? What would their preferred method be?
- Public Accounts Committee: 2016 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Chapter 23: Accounts of the National Treasury Management Agency
National Treasury Management Agency: Financial Statements 2017 (12 Jul 2018) Kate O'Connell: I want a "Yes" or "No" answer. In Mr. Breen's view this would be easier. Has he asked the families and patients what would be easier?